Pyrazine derivatives

Details for Australian Patent Application No. 2011208530 (hide)

Owner AstraZeneca AB

Inventors Feng, Tao; Sanganee, Hitesh Jayantilal; Wada, Hiroki

Agent Davies Collison Cave

Pub. Number AU-A-2011208530

PCT Pub. Number WO2011/089416

Priority 61/296,196 19.01.10 US

Filing date 18 January 2011

Wipo publication date 28 July 2011

International Classifications

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

A61K 31/397 - having four-membered rings, e.g. azetidine

A61P 3/10 Drugs for disorders of the metabolism

A61P 25/00 Drugs for disorders of the nervous system

Event Publications

9 August 2012 PCT application entered the National Phase

  PCT publication WO2011/089416 Priority application(s): WO2011/089416

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011208541-Non-invasive spectrophotometer and related method

2011208529-Combination of a mop head and wringing device